IKK-β

IKK-β (IKBKB) is a catalytic subunit of the IκB kinase (IKK) complex and functions as a central signal integration node that regulates canonical NF-κB signaling, inflammatory responses, cell survival, and immune activation^[1]. Mechanistically, activated IKK-β phosphorylates inhibitory IκB proteins, promoting their ubiquitin-dependent degradation and releasing NF-κB transcription factors for nuclear translocation and target gene expression^[2]. Through this pathway, IKK-β links extracellular inflammatory stimuli to transcriptional programs that control cytokine production, stress responses, and cellular adaptation^[1][3]. In disease contexts, dysregulated IKK-β/NF-κB signaling has been associated with chronic inflammation, cancer, metabolic disorders, cardiovascular disease, and pathogen-driven pathology, making the kinase a widely studied experimental target^[1][3]. Compared with the related catalytic isoform IKK-α (CHUK), IKK-β is the predominant kinase mediating canonical NF-κB activation in a NEMO-dependent manner, whereas IKK family members also participate in additional signaling networks beyond classical NF-κB regulation^[4]. This functional distinction is important for mechanistic studies aimed at dissecting pathway-specific signaling outputs and inflammatory phenotypes^[4]. For experimental applications, pharmacological or genetic inhibition of IKK-β is commonly used to suppress NF-κB activation and evaluate the contribution of inflammatory signaling to disease models, while the expanding spectrum of IKK substrates continues to inform the interpretation of inhibitor-based studies^[3][4].